Clinical investigation summit to focus on representative health
By The Star Staff
To emphasize the value of representative health and encourage people to collaborate with scientific advancements, the Puerto Rico Consortium for Clinical Investigation (PRCCI) will host its 2021 Summit, third edition, focused on “Aligning Global Partnerships and Community Engagement with Clinical Research: Opportunities Beyond the Pandemic,” PRCCI Executive Director Amarilys Silva-Boschetti announced recently.
The virtual event for healthcare professionals and those interested in clinical research will run from 1 p.m. to 5:30 p.m. next Thursday and Friday, Oct. 28 and 29.
Silva-Boschetti will open the event along with Puerto Rico Science, Technology and Research Trust CEO Luz A. Crespo Valentín; Dr. Lester Martínez López, major general (Retired) of the U.S. Army; and Puerto Rico Health Secretary Dr. Carlos Mellado López, who is also chairman of the PRCCI board of directors.
Keynote speaker Dr. Richard H. Carmona, the 17th surgeon general of the United States (2002 to 2006), will enrich the clinical investigation exchange with his
presentation “COVID-19: the Great Divider, Uniter, and Accelerator,” in alignment with a group of 20 other distinguished local and international speakers.
The agenda includes individual presentations, panel discussions and question-and-answer sessions addressing core topics such as securing community engagement and community stakeholders for clinical services and clinical research, refining and re-defining telemedicine and telehealth, globally partnered health clinics and training, sharing expertise remotely, and ongoing clinical intervention and public health challenges.
The PRCCI executive director stressed the vital role of representative health going forward.
“The interaction between patients and communities is a way of building trust among them, promote more participation in clinical studies and achieve scientific results with proper population representation,” said Silva-Boschetti, who has a solid background in clinical research, medical affairs, pharmaco-vigilance, outcomes research, managed care and regulatory affairs throughout manufacturing operations around the world.
“We need the active participation of everyone,” she said. “Innovation and new medical-scientific frontiers may be complex issues for some, but combined with available technology and practices they have the potential of benefitting thousands of patients and generating positive outcomes.”
Silva-Boschetti highlighted the collaboration of PRCCI with Northwell Health, co-sponsor of the summit, and the Yale Center for Clinical Investigation at Yale University. Both generate new opportunities to increase knowledge in clinical research fields, she said.